Ozempic has become a household name for the drug category, though Wegovy, Mounjaro and Zepbound have also skyrocketed in demand for their weight-loss effects
These benefits are reflected in the clinical guidelines published by the American Diabetes Association (ADA) and the American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE), which recommend use of a GLP-1RA or a sodium-glucose co-transporter-2 inhibitor (SGLT2i) with demonstrated CV risk reduction in patients with established/high risk of atherosclerotic CVD (ASCVD), while considering patient-specific factors [15, 17]
So while Id love to drop 20-30 pounds, it almost seems like it would be more work to maintain fitness/muscle as it is to lose fat (because the body is weird like that.) mcneese.chad December 13, 2023, 3:27pm 3 This makes sense for category to me, well done
Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: Impact of preserved small nerve fiber function
The same neural circuitry that governs appetite and food reward also overlaps significantly with the circuitry that drives sexual desire
Published GHK-Cu research does not directly evaluate Wilson's disease patients